Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab
Authors
Keywords
-
Journal
Transplant Infectious Disease
Volume 15, Issue 3, Pages 259-267
Publisher
Wiley
Online
2013-02-14
DOI
10.1111/tid.12061
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT
- (2011) A Dominietto et al. BONE MARROW TRANSPLANTATION
- Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation
- (2011) Z Peric et al. LEUKEMIA
- Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation
- (2010) Stefania Coppoletta et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients
- (2010) Nishitha Reddy et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Prospective Study on Modulation of Immunosuppression for Epstein-Barr Virus Reactivation in Pediatric Patients Who Underwent Unrelated Hematopoietic Stem-Cell Transplantation
- (2010) Simone Cesaro et al. TRANSPLANTATION
- Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation
- (2010) Ben Carpenter et al. TRANSPLANTATION
- Successful Prevention of Acute Graft-versus-Host Disease Using Low-Dose Antithymocyte Globulin after Mismatched, Unrelated, Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia
- (2009) Hee-Je Kim et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Defining the Intensity of Conditioning Regimens: Working Definitions
- (2009) Andrea Bacigalupo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- (2009) O. Landgren et al. BLOOD
- Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children
- (2009) M Faraci et al. BONE MARROW TRANSPLANTATION
- Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases
- (2009) J. Styczynski et al. Transplant Infectious Disease
- Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation
- (2009) Imran Ahmad et al. TRANSPLANTATION
- Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
- (2008) J Styczynski et al. BONE MARROW TRANSPLANTATION
- Kinetics of Epstein-Barr Virus DNA Load in Different Blood Compartments of Pediatric Recipients of T-Cell-Depleted HLA-Haploidentical Stem Cell Transplantation
- (2008) F. Baldanti et al. JOURNAL OF CLINICAL MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started